Testing of oral fluid specimens is becoming increasingly popular in the workplace, prisons and in drug rehabilitation clinics. Its usefulness as an aid in clinical diagnosis has been acknowledged and as a result there are many testing devices on the market for oral fluid screening. Unlike rapid tests, Randox Biochip Array Technology offers a diagnostic grade testing solution with reliable and reproducible results.
Biochip arrays offer a one-shot multiplex assay, detecting up to 97 drugs and drug metabolites from an undivided oral fluid sample. Matrix dedicated kits ensure leading assay performance and excellent specificity, even at lower drug concentrations. Randox biochip arrays meet the limit of detection requirements for both the European Workplace Drug Testing Society guidelines for oral fluid testing (2010) and the Australian and New Zealand procedures for specimen collection and the detection and quantification of drugs in oral fluid AS 4760-2006 (2006).
The Biochip arrays also provide a rapid turn around time. In comparison, a four-plate automated ELISA system would require 13 times longer to process the same results. Randox recently launched a point of collection biochip analyzer, the Evidence MultiStat, which processes multiple results in less than 20 minutes. The Biochip platform is multi-matrix, therefore a number of sample types including oral fluid, whole blood, urine, and post-mortem tissue can be run on the system. The Randox line of evidence immunoassay analyzers generate quality control data automatically with every run.
Source: Randox
